NasdaqGM - Delayed Quote • USD
iTeos Therapeutics, Inc. (ITOS)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 4:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 194.27k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DETHEUX MICHEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 5, 2023 |
| GALL MATTHEW Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 5, 2023 |
| MCGRATH YVONNE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 5, 2023 |
| CALL MATTHEW A MBA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 5, 2023 |
| GALL MATTHEW Chief Financial Officer | Purchase at price 8.37 per share. | Direct | 41,850 | Oct 12, 2023 |
| BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 13.50 - 15.63 per share. | Indirect | 4,952,493 | Aug 23, 2023 |
| CALL MATTHEW A MBA Chief Operating Officer | Conversion of Exercise of derivative security at price 2.95 per share. | Direct | 118,667 | Mar 28, 2023 |
| HALLAL DAVID L Director | Sale at price 19.51 - 20.39 per share. | Direct | 597,214 | Jun 9, 2022 |
| HALLAL DAVID L Director | Conversion of Exercise of derivative security at price 2.95 - 4.23 per share. | Direct | 110,041 | Jun 9, 2022 |
| DAVIS AARON I Director | Sale at price 22.91 - 25.63 per share. | Indirect | 16,444,752 | May 11, 2022 |
| DAVIS AARON I Director | Sale at price 26.91 - 28.22 per share. | Indirect | 10,247,871 | May 2, 2022 |
| DETHEUX MICHEL Chief Executive Officer | Sale at price 31.87 - 32.64 per share. | Direct | 366,530 | Apr 18, 2022 |
| DETHEUX MICHEL Chief Executive Officer | Conversion of Exercise of derivative security at price 4.23 per share. | Direct | 48,645 | Apr 18, 2022 |
| DAVIS AARON I Director | Purchase at price 31.88 - 33.43 per share. | Indirect | 1,625,489 | Mar 23, 2022 |
| DETHEUX MICHEL Chief Executive Officer | Sale at price 33.44 - 36.51 per share. | Direct | 629,987 | Mar 22, 2022 |
| BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 35.25 per share. | Indirect | 20,275,835 | Mar 17, 2022 |
| DETHEUX MICHEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Sale at price 36.01 per share. | Direct | 126,035 | Mar 11, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Conversion of Exercise of derivative security at price 4.30 per share. | Direct | 15,050 | Mar 11, 2022 |
| MCGRATH YVONNE Officer | Sale at price 36.76 per share. | Direct | 367,570 | Mar 1, 2022 |
| MCGRATH YVONNE Officer | Conversion of Exercise of derivative security at price 4.24 per share. | Direct | 42,400 | Mar 1, 2022 |
| DETHEUX MICHEL Chief Executive Officer | Sale at price 34.30 - 35.32 per share. | Direct | 497,905 | Feb 23, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Sale at price 35.52 - 36.27 per share. | Direct | 125,458 | Feb 11, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Conversion of Exercise of derivative security at price 4.30 per share. | Direct | 15,050 | Feb 11, 2022 |
| DETHEUX MICHEL Chief Executive Officer | Sale at price 35.45 - 36.21 per share. | Direct | 517,378 | Jan 25, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Sale at price 39.25 - 39.58 per share. | Direct | 137,614 | Jan 14, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Conversion of Exercise of derivative security at price 4.30 per share. | Direct | 15,050 | Jan 14, 2022 |
| GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security | Sale at price 42.03 - 46.47 per share. | Indirect | 10,452,334 | Jan 5, 2022 |
| MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 42.03 - 46.47 per share. | Indirect | 6,246,050 | Jan 5, 2022 |
| BOXER CAPITAL L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 41.84 - 50.63 per share. | Indirect | 32,575,642 | Jan 4, 2022 |
| BINISZKIEWICZ DETLEV Director | Sale at price 51.90 per share. | Direct | 181,650 | Jan 3, 2022 |
| BINISZKIEWICZ DETLEV Director | Conversion of Exercise of derivative security at price 19.00 per share. | Direct | 66,500 | Jan 3, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Sale at price 51.90 per share. | Direct | 363,300 | Jan 3, 2022 |
| LAGER JOANNE JENKINS M.D. Officer | Conversion of Exercise of derivative security at price 4.30 per share. | Direct | 30,100 | Jan 3, 2022 |
| GALL MATTHEW Chief Financial Officer | Sale at price 46.45 per share. | Direct | 232,250 | Dec 27, 2021 |
| DETHEUX MICHEL Chief Executive Officer | Sale at price 43.94 - 45.37 per share. | Direct | 1,982,131 | Dec 22, 2021 |
| DETHEUX MICHEL Chief Executive Officer | Conversion of Exercise of derivative security at price 4.30 per share. | Direct | 129,000 | Dec 22, 2021 |
| HALLAL DAVID L Director | Sale at price 43.57 per share. | Direct | 2,178,500 | Dec 20, 2021 |
| HALLAL DAVID L Director | Conversion of Exercise of derivative security at price 2.95 - 4.30 per share. | Direct | 174,500 | Dec 20, 2021 |
| LAGER JOANNE JENKINS M.D. Officer | Sale at price 41.00 per share. | Direct | 287,000 | Dec 17, 2021 |
| LAGER JOANNE JENKINS M.D. Officer | Conversion of Exercise of derivative security at price 4.30 per share. | Direct | 30,100 | Dec 17, 2021 |
| LAGER JOANNE JENKINS M.D. Officer | Sale at price 34.50 per share. | Direct | 120,750 | Dec 10, 2021 |
| LAGER JOANNE JENKINS M.D. Officer | Conversion of Exercise of derivative security at price 4.30 per share. | Direct | 15,050 | Dec 10, 2021 |
| GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security | Sale at price 32.35 - 36.26 per share. | Indirect | 2,812,428 | Dec 7, 2021 |
| MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 32.35 - 36.26 per share. | Indirect | 1,680,611 | Dec 7, 2021 |
| MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 32.35 - 36.26 per share. | Indirect | 1,680,611 | Dec 7, 2021 |
| GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security | Sale at price 33.74 - 35.34 per share. | Indirect | 4,817,417 | Dec 2, 2021 |
| MPM BIOVENTURES 2018, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 33.74 - 35.34 per share. | Indirect | 2,878,562 | Dec 2, 2021 |
| GADICKE ANSBERT S. Beneficial Owner of more than 10% of a Class of Security | Sale at price 34.46 - 36.03 per share. | Indirect | 1,356,825 | Nov 29, 2021 |
| MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 34.46 - 36.03 per share. | Indirect | 810,766 | Nov 29, 2021 |
Related Tickers
ENTA Enanta Pharmaceuticals, Inc.
13.15
-2.16%
STRO Sutro Biopharma, Inc.
3.7200
-1.33%
BCAB BioAtla, Inc.
2.2400
+2.75%
IGMS IGM Biosciences, Inc.
7.70
+14.07%
DTIL Precision BioSciences, Inc.
10.23
+5.68%
SEER Seer, Inc.
1.8100
+8.38%
HOWL Werewolf Therapeutics, Inc.
6.44
+5.75%
KYMR Kymera Therapeutics, Inc.
35.71
+3.96%
PASG Passage Bio, Inc.
1.2300
+7.89%
PCVX Vaxcyte, Inc.
60.88
-1.17%